Amylyx Pharmaceuticals, INC. (AMLX) — DEF 14A Filings
All DEF 14A filings from Amylyx Pharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Amylyx Pharma DEF 14A: Executive Compensation Details
— Apr 24, 2025 Risk: low
Amylyx Pharmaceuticals, Inc. filed its DEF 14A on April 24, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, inclu -
Amylyx Pharmaceuticals, Inc. DEF 14A Filing
— Apr 24, 2024 Risk: low
Amylyx Pharmaceuticals, Inc. (AMLX) filed a Proxy Statement (DEF 14A) with the SEC on April 24, 2024. Filing type is DEF 14A, filed on 2024-04-24. Company name
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX